XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2020
Stock Based Compensation [Abstract] |
Stock Based Compensation | 4. Stock-Based Compensation No awards were granted during the six-month period ended June 30, 2020. As of June 30, 2020, there was $102,000 of total unrecognized compensation cost related to non-vested options granted in 2019 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2020. Compensation costs related to stock options amounted to $102,000 and $104,000 during the six-month periods ended June 30, 2020 and 2019, respectively. A summary of the Company’s stock option activity for the six-month period ended June 30, 2020 is as follows:
|  |  | Weighted |  |  |  |  |
|  |  | Average Exercise |  | Weighted Average |  | Aggregate
|  |  | Price |  | Remaining |  | Intrinsic Value
| Options |  | Per Share |  | Contractual Term |  | ($000)
Outstanding at January 1, 2020 | 199,825 |  | $ | 24.78 |  | 5.9 | Yrs. |  | $ | 2,822
Granted | — |  |  | — |  | — |  |  |  | —
Exercised | (2,005) |  |  | 19.25 |  | 5.8 | Yrs. |  |  | —
Forfeited | — |  |  | — |  |  |  |  |  | —
Outstanding at June 30, 2020 | 197,820 |  | $ | 24.83 |  | 5.4 | Yrs. |  | $ | 728
Exercisable at June 30, 2020 | 171,070 |  | $ | 23.08 |  | 4.8 | Yrs. |  | $ | 728
Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $24.79 per share as of June 30, 2020 and $38.90 per share as of December 31, 2019. A summary of the Company’s restricted stock activity for the six-month periods ended June 30, 2020 and 2019 is as follows:
| 2020 |  | 2019
|  |  | Weighted-Average |  |  |  |  | Weighted-Average
| Number of |  | Grant Date |  | Number of |  | Grant Date
| Restricted Stock |  | Fair Value |  | Restricted Stock |  | Fair Value
Non-vested, January 1, | 36,195 |  | $ | 36.23 |  | 34,615 |  | $ | 27.82
Granted | — |  |  | — |  | — |  |  | —
Vested | — |  |  | — |  | — |  |  | —
Forfeited | — |  |  | — |  | — |  |  | —
Non-vested, June 30, | 36,195 |  | $ | 36.23 |  | 34,615 |  | $ | 27.82
The expected future compensation expense relating to the 36,195 shares of non-vested restricted stock outstanding as of June 30, 2020 is $979,000. This cost will be recognized over the remaining vesting period of 4.5 years. Compensation costs related to restricted stock amounted to $167,000 and $145,000 during the six-month periods ended June 30, 2020 and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration